Neurons that die early in Alzheimer’s help drive brain waste removal. Treating this process sooner could change outcomes.

An Australian biotech company developing next-gen anti-inflammatory drugs has announced its breakthrough dementia treatment, designed to preserve the integrity of vital brain cell structures and ...

The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest with recent years witnessing several important controversies.

Tau proteins play a key role in maintaining the structure and function of neurons or brain cells. ... "Most Alzheimer's drugs that pass tests in animals fail in clinical trials in people.

Explore the link between α2,6-sialyltransferase-I and Alzheimer's disease progression. Understand the new findings on ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the secret to staving off Alzheimer’s, too.

New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.

Over a decade ago, a smattering of studies suggested that early cousins of drugs like Ozempic and Mounjaro could prevent, or even reverse, signs of Alzheimer’s disease in mice. Now, as the next ...

Why Alzheimer's disease strikes some people but not others is still largely mysterious. But in about 1% of cases, that reason is clear—the person has inherited one of a handful of mutations that ...

A team of scientists including UCL researchers has tested four anti-amyloid Alzheimer's therapeutics to find out how the drugs bind to toxic amyloid beta protein to tackle the disease.

The UK’s National Institute for Health and Care Excellence (Nice) has declined to recommend two new Alzheimer’s drugs for ...

A class of HIV drugs known as nucleotide reverse transcriptase inhibitors (NRTIs) may help prevent Alzheimer’s disease, reducing risk by up to 13%, a new study suggests.